FOLLOW US :
  • |
  • |

Equity

Daily Market Tracker
Market Analysis
Other Markets
Corporate Actions
News
Corporate Information

Prev Quarter Comp Home > Equity > Corporate Information > Prev Quarter Comp

Nectar Lifescience LtdIndustry : Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code:532649 NSE Symbol: NECLIFE P/E (TTM) :0
ISIN Demat:INE023H01027 Div & Yield %:0 EPS (TTM) :0
Book Value (RS) :42.6340837 Market Cap (Rs Cr.):436.64 Face Value (RS) :1
    Change Company 
Particulars Quarter Ended
(Mar 2025)		 Quarter Ended
(Mar 2024)		 Quarter Ended
(% Var)
Sales 428.91 439.85 -2.49
Other Income 0.08 1.47 -94.56
PBIDT -154.23 49.98 -408.58
Interest 17.67 24.16 -26.86
PBDT -171.90 25.82 -765.76
Depreciation 15.77 14.70 7.28
PBT -187.67 11.12 -1,787.68
Tax 0.00 0.00 0.00
Deferred Tax -57.58 10.52 -647.34
PAT -130.09 0.60 -21,781.67

IMPORTANT LINKS

QUICK LINKS

FOR GRIEVANCE MAIL TO invgrieviss@iseindia.com

BSE EQUITIES : INB011077733 | NSE F&O EQUITIES : INF231077737 | NSE CASH MARKET : INB231077737 | NSE CURRENCY DERIVATIVES : INE231077737 | MCX-SX : INE261077737

ISS Enterprise Limited [Erstwhile: ISE Securities & Services Limited], a wholly owned subsidiary of Inter-connected Stock Exchange of India Ltd. (ISE)

© 2013 ISS Enterprise Limited [Erstwhile: ISE Securities & Services Limited]. All rights reserved.

Designed, developed & powered by C-MOTS Infotech (ISO 9001:2008 certified)